State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
+10.6%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$51.8B
AUM Growth
+$3.52B
(+7.3%)
Cap. Flow
-$623M
Cap. Flow
% of AUM
-1.2%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
2,298
New
187
Increased
544
Reduced
971
Closed
155
Top Buys
| 1 |
ARK Innovation ETF
ARKK
|
+$89.1M |
| 2 |
Colgate-Palmolive
CL
|
+$69.6M |
| 3 |
NVIDIA
NVDA
|
+$63M |
| 4 |
Amazon
AMZN
|
+$57.6M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$56.6M |
Top Sells
| 1 |
Apple
AAPL
|
+$87.6M |
| 2 |
Microsoft
MSFT
|
+$65.4M |
| 3 |
News Corp Class B
NWS
|
+$63.5M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$45.2M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$45.1M |
Sector Composition
| 1 | Technology | 24.81% |
| 2 | Financials | 13.05% |
| 3 | Healthcare | 12.65% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Communication Services | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Jabil
JBL
$23B
| $1.26M | ﹤0.01% |
17,897
+88
| +0.5% | +$6.19K |
|
1377
Madrigal Pharmaceuticals
MDGL
$9.63B
| $1.25M | ﹤0.01% |
14,800
| – | – |
|
|
ITOS
1378
DELISTED
iTeos Therapeutics
ITOS
| $1.25M | ﹤0.01% |
26,900
+11,900
| +79% | +$554K |
|
1379
Inovio Pharmaceuticals
INO
$126M
| $1.24M | ﹤0.01% |
20,775
| – | – |
|
1380
Harmony Biosciences
HRMY
$1.86B
| $1.24M | ﹤0.01% |
29,100
| – | – |
|
1381
Axon Enterprise
AXON
$59.4B
| $1.24M | ﹤0.01% |
7,890
-241
| -3% | -$37.8K |
|
|
SOHU
1382
Sohu.com
SOHU
$480M
| $1.24M | ﹤0.01% |
75,949
+30,202
| +66% | +$492K |
|
1383
Reliance Steel & Aluminium
RS
$15.3B
| $1.23M | ﹤0.01% |
7,598
-340
| -4% | -$55.2K |
|
1384
Lamb Weston
LW
$7.86B
| $1.23M | ﹤0.01% |
19,356
-132,139
| -87% | -$8.38M |
|
1385
Rocket Pharmaceuticals
RCKT
$341M
| $1.22M | ﹤0.01% |
56,000
-3,200
| -5% | -$69.8K |
|
1386
Instil Bio
TIL
$163M
| $1.22M | ﹤0.01% |
3,570
+2,440
| +216% | +$835K |
|
1387
Deckers Outdoor
DECK
$17.6B
| $1.22M | ﹤0.01% |
19,980
-612
| -3% | -$37.4K |
|
|
ENDP
1388
DELISTED
Endo International plc
ENDP
| $1.22M | ﹤0.01% |
323,200
| – | – |
|
1389
Penumbra
PEN
$10.6B
| $1.21M | ﹤0.01% |
4,221
-12
| -0.3% | -$3.45K |
|
|
BIOT
1390
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
| $1.21M | ﹤0.01% |
+123,284
| New | +$1.21M |
|
1391
Kezar Life Sciences
KZR
$28.9M
| $1.21M | ﹤0.01% |
7,220
+2,910
| +68% | +$486K |
|
1392
Cleveland-Cliffs
CLF
$5.78B
| $1.21M | ﹤0.01% |
55,417
-1,681
| -3% | -$36.6K |
|
1393
Manhattan Associates
MANH
$13.1B
| $1.2M | ﹤0.01% |
7,697
-235
| -3% | -$36.5K |
|
1394
Zions Bancorporation
ZION
$8.62B
| $1.19M | ﹤0.01% |
18,818
-1,191
| -6% | -$75.3K |
|
1395
MacroGenics
MGNX
$100M
| $1.18M | ﹤0.01% |
73,800
| – | – |
|
1396
Kura Oncology
KURA
$711M
| $1.18M | ﹤0.01% |
84,300
| – | – |
|
1397
Amphastar Pharmaceuticals
AMPH
$1.3B
| $1.18M | ﹤0.01% |
50,600
| – | – |
|
1398
Amdocs
DOX
$9.35B
| $1.18M | ﹤0.01% |
15,734
-480
| -3% | -$35.9K |
|
1399
Nurix Therapeutics
NRIX
$691M
| $1.17M | ﹤0.01% |
40,500
| – | – |
|
1400
Capri Holdings
CPRI
$2.43B
| $1.17M | ﹤0.01% |
17,964
-647
| -3% | -$42K |
|